Diplomat blasts CNN’s media blitz against Russia's US envoyRussian Politics & Diplomacy May 25, 16:19
Russian diplomat warns about possible escalation of violence in SyriaRussian Politics & Diplomacy May 25, 15:42
OPEC welcomes its new memberBusiness & Economy May 25, 15:40
Russian diplomat to nominate deputy FM Nebenzya to position of UN ambassadorRussian Politics & Diplomacy May 25, 15:11
Russian watchdog vows messengers bill won’t mean ‘control over private correspondence’Russian Politics & Diplomacy May 25, 15:02
Russia’s advanced Ka-62 helicopter performs debut flightMilitary & Defense May 25, 14:58
Russia's military satellite delivered into orbitScience & Space May 25, 14:51
Iran builds third underground missile plantWorld May 25, 14:27
Russia’s cutting-edge multipurpose helicopter to be certified in AugustMilitary & Defense May 25, 14:13
MOSCOW, October 17. /TASS/. Russian tennis star Maria Sharapova has no plans of arriving in Moscow to watch the Kremlin Cup tennis tournament, which kicked off today in the Russian capital, Shamil Tarpishchev, the president of the Russian Tennis Federation (RTF), told TASS on Monday.
"No, she is staying in the United States and continues practicing there," Tarpishchev said in an interview with TASS when asked whether Sharapova would come as a guest to the Kremlin Cup.
The Kremlin Cup is held at the Moscow Olympic Stadium between October 15 and 23 and has $1.5 million in prize money up for grabs.
Sharapova, who is currently under suspension over anti-doping rules violations, has been allowed by the International Tennis Federation (ITF) to play at exhibition matches before her ban expires.
The tennis player has been serving a two-year suspension for the violation of anti-doping regulations since January 26. However, the Swiss-based Court of Arbitration for Sport (CAS) ruled October 4 to reduce her suspension term from 24 to 15 months.
The Russian player is now eligible to officially return back to tennis courts starting April 26 next year.
In early March, Sharapova was first to announce that her doping tests revealed the presence of performance enhancing drug meldonium in the body system. Following the announcement, former World’s No. 1 was provisionally suspended from all tennis-related activities.
On June 9, Sharapova filed an appeal with the CAS in Switzerland’s Lausanne against her two-year suspension, which was officially announced on June 8 by the International Tennis Federation (ITF) Tribunal over anti-doping violations.
Due to the imposed ban Sharapova, the silver Olympic medalist of the 2012 Games in London, had to miss the 2016 Summer Olympic Games, held in August in Brazil’s Rio de Janeiro.
Mildronate is a cardiovascular preparation freely available for purchase at pharmacies across Russia without a doctor’s prescription.